Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma.

Bu DX, Singh R, Choi EE, Ruella M, Nunez-Cruz S, Mansfield KG, Bennett P, Barton N, Wu Q, Zhang J, Wang Y, Wei L, Cogan S, Ezell T, Joshi S, Latimer KJ, Granda B, Tschantz WR, Young RM, Huet HA, Richardson CJ, Milone MC.

Oncotarget. 2018 May 25;9(40):25764-25780. doi: 10.18632/oncotarget.25359. eCollection 2018 May 25.

2.

Long-acting protein drugs for the treatment of ocular diseases.

Ghosh JG, Nguyen AA, Bigelow CE, Poor S, Qiu Y, Rangaswamy N, Ornberg R, Jackson B, Mak H, Ezell T, Kenanova V, de la Cruz E, Carrion A, Etemad-Gilbertson B, Caro RG, Zhu K, George V, Bai J, Sharma-Nahar R, Shen S, Wang Y, Subramanian KK, Fassbender E, Maker M, Hanks S, Vrouvlianis J, Leehy B, Long D, Prentiss M, Kansara V, Jaffee B, Dryja TP, Roguska M.

Nat Commun. 2017 Mar 23;8:14837. doi: 10.1038/ncomms14837.

3.

Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatrogenic opiate withdrawal.

Lewis T, Erfe BL, Ezell T, Gauda E.

J Opioid Manag. 2015 Jul-Aug;11(4):305-12. doi: 10.5055/jom.2015.0279.

4.

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.

Johnson LA, Scholler J, Ohkuri T, Kosaka A, Patel PR, McGettigan SE, Nace AK, Dentchev T, Thekkat P, Loew A, Boesteanu AC, Cogdill AP, Chen T, Fraietta JA, Kloss CC, Posey AD Jr, Engels B, Singh R, Ezell T, Idamakanti N, Ramones MH, Li N, Zhou L, Plesa G, Seykora JT, Okada H, June CH, Brogdon JL, Maus MV.

Sci Transl Med. 2015 Feb 18;7(275):275ra22. doi: 10.1126/scitranslmed.aaa4963.

5.

Breathing and temperature control disrupted by morphine and stabilized by clonidine in neonatal rats.

Kesavan K, Ezell T, Bierman A, Nunes AR, Northington FJ, Tankersley CG, Gauda EB.

Respir Physiol Neurobiol. 2014 Sep 15;201:93-100. doi: 10.1016/j.resp.2014.06.015. Epub 2014 Jul 5.

6.

Effect of development on [Ca2+]i transients to ATP in petrosal ganglion neurons: a pharmacological approach using optical recording.

Nunes AR, Chavez-Valdez R, Ezell T, Donnelly DF, Glover JC, Gauda EB.

J Appl Physiol (1985). 2012 Apr;112(8):1393-402. doi: 10.1152/japplphysiol.00511.2011. Epub 2012 Jan 12.

7.

Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants.

Chavez Valdez R, Ahlawat R, Wills-Karp M, Nathan A, Ezell T, Gauda EB.

J Pediatr. 2011 Jan;158(1):57-64, 64.e1. doi: 10.1016/j.jpeds.2010.06.051. Epub 2010 Aug 6.

8.

A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.

Aneja R, Miyagi T, Karna P, Ezell T, Shukla D, Vij Gupta M, Yates C, Chinni SR, Zhau H, Chung LW, Joshi HC.

Eur J Cancer. 2010 Jun;46(9):1668-78. doi: 10.1016/j.ejca.2010.02.017. Epub 2010 Mar 18.

9.

Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.

Finn AV, John M, Nakazawa G, Polavarapu R, Karmali V, Xu X, Cheng Q, Davis T, Raghunathan C, Acampado E, Ezell T, Lajoie S, Eppihimer M, Kolodgie FD, Virmani R, Gold HK.

Circ Res. 2009 Nov 6;105(10):1003-12. doi: 10.1161/CIRCRESAHA.109.200519. Epub 2009 Sep 24.

10.

Exposure to the anti-TNF-alpha drug thalidomide induces apoptotic cell death in human T leukemic cells.

Ezell TN, Maloney N, Githua JW, Taylor LD.

Cell Mol Biol (Noisy-le-grand). 2003 Nov;49(7):1117-24.

PMID:
14682394
11.

Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide.

Settles B, Stevenson A, Wilson K, Mack C, Ezell T, Davis MF, Taylor LD.

Cell Mol Biol (Noisy-le-grand). 2001 Nov;47(7):1105-14.

PMID:
11838958

Supplemental Content

Support Center